Discussion – Why Has No Vaccine Made it to Market Yet?

Time: 10:00 am
day: Focus Day


  • Understanding why recombinant cancer vaccines are expected to hold significant market share in the cancer vaccines market
  • Realising the importance of DNA encoding, an antigen which stimulates an immune response into mammalian cells
  • Uncovering numerous studies being conducted in the field of viral recombinant cancer vaccines which may reap positive results in future